PANews reported on March 5th that, according to The Block, Apollo Crypto, Midas, and Everstake jointly launched the USDC-denominated tokenization strategy mEVUSDPANews reported on March 5th that, according to The Block, Apollo Crypto, Midas, and Everstake jointly launched the USDC-denominated tokenization strategy mEVUSD

Apollo launches mEVUSD, a tokenized product offering stable returns, targeting an annualized return of 7%–12%.

2026/03/05 20:25
1 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

PANews reported on March 5th that, according to The Block, Apollo Crypto, Midas, and Everstake jointly launched the USDC-denominated tokenization strategy mEVUSD. This strategy aims to convert idle institutional stablecoins into yield assets through diversified lending and market-neutral basis trading on DeFi protocols such as Aave, Morpho, and Pendle, targeting an annualized return of approximately 7%–12%. Apollo is responsible for risk management and strategy allocation. The product is open to institutional investors in the EU and certain compliant jurisdictions, but not to investors in the US, UK, Canada, China, Australia, or sanctioned regions. Everstake will integrate its self-developed SDK into Midas' audited smart contracts, providing API access for wallets and custodians.

Market Opportunity
Pendle Logo
Pendle Price(PENDLE)
$1,277
$1,277$1,277
-%1,38
USD
Pendle (PENDLE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.